scholarly journals Pulmonary nodule radiological diagnostic algorithm in lung cancer screening

2021 ◽  
Vol 10 (2) ◽  
pp. 1124-1135
Author(s):  
Katarzyna Dziadziuszko ◽  
Edyta Szurowska
2014 ◽  
Vol 14 (S1) ◽  
Author(s):  
MA Heuvelmans ◽  
R Vliegenthart ◽  
N Horeweg ◽  
GJ de Jonge ◽  
PMA van Ooijen ◽  
...  

2017 ◽  
Vol 12 (11) ◽  
pp. S1859-S1860
Author(s):  
R. Yuan ◽  
M. Tammemägi ◽  
A. Ritchie ◽  
B. Dougherty ◽  
C. Sanghera ◽  
...  

2018 ◽  
Vol 41 (3) ◽  
pp. 600-608
Author(s):  
Marcia E Clark ◽  
Ben Young ◽  
Laura E Bedford ◽  
Roshan das Nair ◽  
John F R Robertson ◽  
...  

Abstract Background Lung cancer screening can reduce lung cancer mortality by 20%. Screen-detected abnormalities may provide teachable moments for smoking cessation. This study assesses impact of pulmonary nodule detection on smoking behaviours within the first UK trial of a novel auto-antibody test, followed by chest x-ray and serial CT scanning for early detection of lung cancer (Early Cancer Detection Test–Lung Cancer Scotland Study). Methods Test-positive participants completed questionnaires on smoking behaviours at baseline, 1, 3 and 6 months. Logistic regression compared outcomes between nodule (n = 95) and normal CT groups (n = 174) at 3 and 6 months follow-up. Results No significant differences were found between the nodule and normal CT groups for any smoking behaviours and odds ratios comparing the nodule and normal CT groups did not vary significantly between 3 and 6 months. There was some evidence the nodule group were more likely to report significant others wanted them to stop smoking than the normal CT group (OR across 3- and 6-month time points: 3.04, 95% CI: 0.95, 9.73; P = 0.06). Conclusion Pulmonary nodule detection during lung cancer screening has little impact on smoking behaviours. Further work should explore whether lung cancer screening can impact on perceived social pressure and promote smoking cessation.


2017 ◽  
Vol 7 (1) ◽  
Author(s):  
F. Ciompi ◽  
K. Chung ◽  
S. J. van Riel ◽  
A. A. A. Setio ◽  
P. K. Gerke ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Hassan Baig ◽  
Sushilkumar Sonavane ◽  
Ian Makey ◽  
Jorge Mallea ◽  
Andras Khoor

Pulmonary Langerhans cell histiocytosis (PLCH) is a rare inflammatory condition that mostly affects lungs in smokers. On imaging, it usually presents as multiple, upper lobe predominant, solid, and cavitary nodules, but presentation as solitary pulmonary nodule (SPN) is rare. We describe a case of SPN seen on low-dose lung cancer screening CT (LDCT) that was FDG avid on PET/CT. Given concern for malignancy, lobectomy was planned if intraoperative frozen section was consistent with malignancy. Lobectomy was performed based on frozen section; however, on formal pathology review, the nodule was ultimately found to be PLCH. This case illustrates an atypical presentation of PLCH as a solitary nodule. Furthermore, it helps demonstrate how rare etiologies (like PLCH) may be more frequently encountered and should be considered in the differential diagnosis for solitary lung nodules, especially in the era of lung cancer screening.


Sign in / Sign up

Export Citation Format

Share Document